Risk prediction is improved by adding markers of subclinical organ damage to SCORE

被引:212
|
作者
Sehestedt, Thomas [1 ,2 ]
Jeppesen, Jorgen [1 ]
Hansen, Tine W. [2 ,3 ]
Wachtell, Kristian [4 ]
Ibsens, Hans [5 ]
Torp-Petersen, Christian [6 ]
Hildebrandt, Per [1 ]
Olsen, Michael H. [1 ]
机构
[1] Glostrup Univ Hosp, Dept Internal Med, Cardiovasc Res Unit, DK-2600 Glostrup, Denmark
[2] Res Ctr Prevent & Hlth, Copenhagen, Denmark
[3] Hvidovre Univ Hosp, Dept Clin Physiol & Nucl Med, DK-2650 Hvidovre, Denmark
[4] Rigshosp, Dept Cardiol, Copenhagen, Denmark
[5] Holbaek Cent Hosp, Dept Internal Med, Holbaek, Denmark
[6] Gentofte Univ Hosp, Dept Cardiol, Gentofte, Denmark
关键词
Risk stratification; SCORE; Atherosclerotic plaques; Albuminuria; Pulse wave velocity; Left ventricular hypertrophy; CORONARY-HEART-DISEASE; BRAIN NATRIURETIC PEPTIDE; LEFT-VENTRICULAR MASS; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK; MYOCARDIAL-INFARCTION; PRIMARY HYPERTENSION; AORTIC STIFFNESS; ROC CURVE; MICROALBUMINURIA;
D O I
10.1093/eurheartj/ehp546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims It is unclear whether subclinical vascular damage adds significantly to Systemic Coronary Risk Evaluation (SCORE) risk stratification in healthy subjects. Methods and results In a population-based sample of 1968 subjects without cardiovascular disease or diabetes not receiving any cardiovascular, anti-diabetic, or lipid-lowering treatment, aged 41, 51, 61, or 71 years, we measured traditional cardiovascular risk factors, left ventricular (LV) mass index, atherosclerotic plaques in the carotid arteries, carotid/femoral pulse wave velocity (PWV), and urine albumin/creatinine ratio (UACR) and followed them for a median of 12.8 years. Eighty-one subjects died because of cardiovascular causes. Risk of cardiovascular death was independently of SCORE associated with LV hypertrophy [hazard ratio (HR) 2.2 (95% Cl 1.2-4.0)], plaques [HR 2.5 (1.6-4.0)], UACR >= 90th percentile [HR 3.3 (1.8-5.9)], PWV > 12 m/s [HR 1.9 (1.1-3.3) for SCORE >= 5% and 7.3 (3.2-16.1) for SCORE < 5%]. Restricting primary prevention to subjects with SCORE >= 5% as well as subclinical organ damage, increased specificity of risk prediction from 75 to 81% (P < 0.002), but reduced sensitivity from 72 to 65% (P = 0.4). Broaden primary prevention from subjects with SCORE >= 5% to include subjects with 1% <= SCORE < 5% together with subclinical organ damage increased sensitivity from 72 to 89% (P = 0.006), but reduced specificity from 75 to 57% (P < 0.002) and positive predictive value from 11 to 8% (P = 0.07). Conclusion Subclinical organ damage predicted cardiovascular death independently of SCORE and the combination may improve risk prediction.
引用
收藏
页码:883 / 891
页数:9
相关论文
共 50 条
  • [1] Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?
    Sehestedt, Thomas
    Jeppesen, Jorgen
    Hansen, Tine W.
    Rasmussen, Susanne
    Wachtell, Kristian
    Ibsen, Hans
    Torp-Pedersen, Christian
    Olsen, Michael H.
    JOURNAL OF HYPERTENSION, 2009, 27 (06) : 1165 - 1171
  • [2] Subclinical organ damage and cardiovascular risk prediction
    Sehestedt, Thomas
    Olsen, Michael H.
    BLOOD PRESSURE, 2010, 19 (03) : 132 - 139
  • [3] Adding markers of organ damage to risk score models improves cardiovascular risk assessment: Prospective analysis of a large cohort of adult outpatients
    Tocci, Giuliano
    Figliuzzi, Ilaria
    Presta, Vivianne
    El Halabieh, Nadia Attalla
    Citoni, Barbara
    Coluccia, Roberta
    Battistoni, Allegra
    Ferrucci, Andrea
    Volpe, Massimo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 248 : 342 - 348
  • [4] Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy
    Olsen, Michael H.
    Wachtell, Kristian
    Ibsen, Hans
    Lindholm, Lars
    Kjeldsen, Sverre E.
    Omvik, Per
    Nieminen, Markku S.
    Dahlof, Bjorn
    Okin, Peter M.
    Devereux, Richard B.
    JOURNAL OF HYPERTENSION, 2011, 29 (05) : 997 - 1004
  • [5] Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study
    Graversen, Peter
    Abildstrom, Steen Z.
    Jespersen, Lasse
    Borglykke, Anders
    Prescott, Eva
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (14) : 1546 - 1556
  • [6] Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers
    Volpe, Massimo
    Battistoni, Allegra
    Tocci, Giuliano
    Rosei, Enrico Agabiti
    Catapano, Alberico L.
    Coppo, Rosanna
    del Prato, Stefano
    Gentile, Sandro
    Mannarino, Elmo
    Novo, Salvatore
    Prisco, Domenico
    Mancia, Giuseppe
    JOURNAL OF HYPERTENSION, 2012, 30 (06) : 1056 - 1064
  • [7] Associations of dietary patterns with blood pressure and markers of subclinical arterial damage in adults with risk factors for CVD
    Tzelefa, Vicky
    Tsirimiagkou, Christiana
    Argyris, Antonios
    Moschonis, George
    Perogiannakis, George
    Yannakoulia, Maria
    Sfikakis, Petros
    Protogerou, Athanase D.
    Karatzi, Kalliopi
    PUBLIC HEALTH NUTRITION, 2021, 24 (18) : 6075 - 6084
  • [8] Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score
    Tzoulaki, Ioanna
    Liberopoulos, George
    Ioannidis, John P. A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (21): : 2345 - 2352
  • [9] High Burden of Subclinical Cardiovascular Target Organ Damage After Pediatric Liver Transplantation
    Memaran, Nima
    Borchert-Moerlins, Bianca
    Schmidt, Bernhard M. W.
    Sugianto, Rizky, I
    Wilke, Hannes
    Bloete, Ricarda
    Baumann, Ulrich
    Bauer, Elena
    von Wick, Anika
    Junge, Norman
    Leiskau, Christoph
    Pfister, Eva D.
    Thurn-Valsassina, Daniela
    Richter, Nicolas
    Goldschmidt, Imeke
    Melk, Anette
    LIVER TRANSPLANTATION, 2019, 25 (05) : 752 - 762
  • [10] Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events
    Sehestedt, T.
    Lyngbaek, S.
    Eugen-Olsen, J.
    Jeppesen, J.
    Andersen, O.
    Hansen, T. W.
    Linneberg, A.
    Jorgensen, T.
    Haugaard, S. B.
    Olsen, M. H.
    ATHEROSCLEROSIS, 2011, 216 (01) : 237 - 243